Imp - Profile
✉ Email this page to a colleague
Drugs and US Patents for Imp
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Impax Labs | CORTISONE ACETATE | cortisone acetate | TABLET;ORAL | 009458-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Impax Labs Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 205105-004 | Jul 28, 2016 | AB2 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Impax Labs Inc | LEVALBUTEROL HYDROCHLORIDE | levalbuterol hydrochloride | SOLUTION;INHALATION | 077756-001 | Apr 9, 2008 | AN | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Impax | BACLOFEN | baclofen | TABLET;ORAL | 077971-003 | Jul 7, 2021 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Impax Labs | RESERPINE | reserpine | TABLET;ORAL | 009627-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Impax Labs Inc | ALPRAZOLAM | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 077996-004 | Jan 31, 2007 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Impax Labs Inc | GLYBURIDE AND METFORMIN HYDROCHLORIDE | glyburide; metformin hydrochloride | TABLET;ORAL | 076345-002 | Feb 18, 2004 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |